Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Jun 18, 2021

5250_rns_2021-06-18_97b767ec-23da-4c4c-9f8c-5e97a9e05b39.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - UDG HEALTHCARE PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in UDG HEALTHCARE PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 17 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
7,394,684 2.94% 144,851 0.06%
(2) Derivatives (other than options):
92,243 0.04% 6,909,819 2.74%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
7,486,927 2.97% 7,054,670 2.80%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 7 10.4971 GBP
Purchase 355 10.4972 GBP
Purchase 409 10.4871 GBP
Purchase 528 10.5100 GBP
Purchase 1,050 10.5109 GBP
Purchase 1,596 10.5275 GBP
Purchase 1,882 10.5324 GBP
Purchase 2,199 10.4700 GBP
Purchase 2,242 10.5096 GBP
Purchase 2,419 10.4789 GBP
Purchase 2,969 10.4800 GBP
Purchase 3,818 10.5000 GBP
Purchase 5,969 10.4955 GBP
Purchase 25,850 10.4828 GBP
Purchase 37,822 10.5238 GBP
Purchase 76,865 10.4906 GBP
Purchase 666,141 10.4826 GBP
Sale 6 10.4891 GBP
Sale 24 10.4943 GBP
Sale 152 10.4700 GBP
Sale 738 10.5108 GBP
Sale 787 10.5900 GBP
Sale 1,091 10.4702 GBP
Sale 1,265 10.5000 GBP
Sale 1,307 10.5344 GBP
Sale 1,371 10.4987 GBP
Sale 2,011 10.4680 GBP
Sale 2,419 10.4800 GBP
Sale 2,468 10.4776 GBP
Sale 2,762 10.5134 GBP
Sale 2,812 10.5124 GBP
Sale 2,841 10.4833 GBP
Sale 3,125 10.4914 GBP
Sale 3,157 10.5500 GBP
Sale 3,296 10.4790 GBP
Sale 3,579 10.5067 GBP
Sale 3,932 10.5222 GBP
Sale 4,070 10.4788 GBP
Sale 7,912 10.4848 GBP
Sale 8,191 10.5164 GBP
Sale 12,621 10.5165 GBP
Sale 13,357 10.4863 GBP
Sale 18,114 10.4600 GBP
Sale 31,808 10.5228 GBP
Sale 59,811 10.5132 GBP

(b) Derivatives transactions (other than options transactions)

Product Name Nature of transaction Number of relevant securities Price per
unit
CFD Long 6 10.4900 GBP
SWAP Long 319 10.4791 GBP
SWAP Long 6,846 10.5128 GBP
SWAP Long 11,830 10.4902 GBP
SWAP Long 21,469 10.4954 GBP
SWAP Long 31,148 10.5191 GBP
SWAP Short 145 10.4870 GBP
CFD Short 1,231 10.5114 GBP
SWAP Short 1,876 10.4889 GBP
SWAP Short 9,267 10.5000 GBP
SWAP Short 23,452 10.4998 GBP
SWAP Short 34,590 10.5003 GBP

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 18 Jun 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

View source version on businesswire.com: https://www.businesswire.com/news/home/20210618005233/en/

BARCLAYS PLC